🔴 Decoy Therapeutics is trading 10.9% down today, giving back gains from its recent two-day rebound

Decoy Therapeutics is trading 10.9% down at $3.60, giving back part of its sharp two-day rebound following a period of high volatility.

• The move follows a July 28 report highlighting the lab success of the company's antiviral platform against Ebola Zaire, though execution remains a challenge given its ~$3 million micro-cap valuation.
• There is no fresh company-specific catalyst clearly tied to this morning's price action, suggesting a technical pullback after the recent rally.